|
General Information
|
|
|
Product
|
Cannabinoid Receptor II Antibody FITC
|
|
Description
|
FITC-Conjugated Cannabinoid receptor 2 Antibody
|
|
Verified Applications
|
ELISA, IHC, IP, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Human, Mouse, Rat
|
|
Immunogen
|
Synthetic peptide taken within amino acid region 300-350 on mouse CB2 Receptor protein common to both CB2L and CB2S.
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.61-0.63 µg/µl in antibody stabilization buffer
|
|
Form
|
FITC-Conjugated
|
|
Clonality
|
Polyclonal
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
|
DB
|
1:10,000
|
|
ELISA
|
1:10,000
|
| Immunohistochemistry |
1:50-1:150 |
| Immunoprecipitation |
1:200 |
|
Western Blot
|
1:500
|
|
Protein
|
|
|
Uniprot #
|
P47936
|
|
Overview
|
Heterotrimeric GPCR for endocannabinoid 2-arachidonoylglycerol mediating inhibition of Adenylate cyclase. Functions in inflammatory response, nociceptive transmission and bone homeostasis.
|
|
Molecular Function
|
Inflammatory response; GPCR; Receptor; Transducer
|
|
Subcellular Location
|
Cell membrane; Multi-pass membrane protein; Dendrite; Perikaryon
|
|
Expression
|
Cells of hematopoietic origin. Expressed in skin in suprabasal layers and hair follices. In brain by neurons and glial cells. Expressed in osteoblasts, osteocytes and osteoclasts.
|
|
Structure
|
belongs to G-protein coupled receptor 1 family
|
|
Alternative Nomenclature
|
Cannabinoid receptor 2 macrophage antibody
CB 2 antibody
CNR2 antibody
CX 5 antibody
testis-dominant CNR2 isoform CB2 antibody
|
Cannabinoid Receptor 2 Antibody
Cannabinoid Receptor II Blocking Peptide
Cannabinoid Receptor II Antibody BIOTIN
Cannabinoid Receptor II Positive Control
